ESH Video

WELCOME TO #ESHCLL2022

March 17, 2022
 

ESH 2nd Translational Research Conference
CHRONIC LYMPHOCYTIC LEUKAEMIA


E-CONFERENCE
March 17-20, 2022

#ESHCLL2022


FREE REGISTRATION



 

 
Click here to see the Full programme



Highlights of Day 1


14:00-14:05  Welcome
Jennifer Brown (Boston), Paolo Ghia (Milan), Michael Hallek (Cologne)


14:05-15:30 Session I: Spectrum of CLL disease: MBL to Richter’s transformation
Chairs: Michael Hallek (Cologne), Silvia Deaglio (Turin)
Interactive Live Discussion at 15:00

15:40-17:05 Session II: New insights in “old” biomarkers
Chairs: Paolo Ghia (Milan), Sarka Pospisilova (Brno)
Interactive Live Panel Discussion at 16:35

18:25-19:25 Mentored Poster Walk
Leaders: Carsten Utoft Niemann (Copenhagen), Sigrid Skånland (Oslo)


Highlights of Day 2


14:10-15:35 Session III: Taking driver gene mutations to the next level
Chairs: Jennifer Brown (Boston), Davide Rossi (Bellinzona)
Interactive Live Panel Discussion at 15:05

15:45-17:40 Session IV: Beyond BcR: other microenvironmental stimuli
Chairs: : Elisa Ten Hacken (Boston), Chris Pepper (Brighton)

Interactive Live Panel Discussion at 17:15

19:00-20:00  3 Simultaneous Meet the Expert sessions
PRE-REGISTRATION REQUIRED
- Pathogenesis and Transformation

Elisa Ten Hacken (Boston), Kostas Stamatopoulos (Thessaloniki)
- TP53 where are we standing?
Sarka Pospisilova (Brno), Arnon Kater (Amsterdam)
- Microenvironment and therapeutic options
Adrian Wiestner (Bethesda), Silvia Deaglio (Turin)


Highlights of Day 3


14:10-15:35 Session V: Time-limited therapy
Chairs: Arnon Kater (Amsterdam), John Allan (New York) Interactive Live Panel Discussion at 15:05

15:45-16:55 Session VI: Covalent BTK inhibitors
Chairs: Vincent Lévy (Bobigny), Othman Al-Sawaf (Cologne)

Interactive Live Discussion at 16:25

17:05-18:30 Session VII: BTK and Bcl2 inhibitor resistance
Chairs: Lukas P. Frenzel (Cologne), Adrian Wiestner (Bethesda)

Interactive Live Discussion at 18:00

 

Highlights of Day 4

 
13:00-14:00  3 Simultaneous Meet the Expert sessions
PRE-REGISTRATION REQUIRED
- Combination therapies

Othman Al-Sawaf (Cologne), Florence Cymbalista (Bobigny)
- Future therapies including CAR-T therapies
John Gribben (London), Tanya Siddiqi (Duarte)
- Patient selection for time limited versus continued therapy
Jennifer Brown (Boston) Antony Mato (New York)

14:10-15:35 Session VIII: Next generation therapies
Chairs: John Gribben (London), Sanne H. Tonino (Amsterdam)
Interactive Live Panel Discussion at 15:05

15:45-17:10 Session IX: The future: other targets
Chairs: Michael Hallek (Cologne), Jennifer Brown (Boston), Paolo Ghia (Milan)
Interactive Live Panel Discussion at 16:40

17:10-17:15  Closing remarks



Meet the faculty






WELCOME WORDS FROM THE E-CONFERENCE CHAIRPERSONS



E-CONFERENCE MAIN TOPICS:

• Spectrum of CLL disease: MBL to Richter’s transformation
• New insights in “old” biomarkers
• Taking driver gene mutations to the next level
• Beyond BcR: other microenvironmental stimuli
• Time-limited therapy
• Covalent BTK inhibitors
• BTK and Bcl2 inhibitor resistance
• Next generation therapies
• The future: other targets




About the E-Conference:

The 2nd ESH 2nd TRANSLATIONAL RESEARCH CONFERENCE ON CHRONIC LYMPHOCYTIC LEUKAEMIA is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.

This translational research E-Conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease. Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.

SCIENTIFIC PROGRAMME


MORE INFORMATION



REGISTRATION IS NOW OPEN
FOR THE MEET THE EXPERT SESSIONS

SEATS ARE LIMITED
AND PRE-REGISTRATION IS REQUIRED

DO NOT MISS THE OPPORTUNITY!




About the Meet the Expert sessions:

The ESH 2nd Translational Research Conference on CHRONIC LYMPHOCYTIC LEUKAEMIA Meet the Expert sessions are live, interactive sessions that offer you an opportunity for informal dialogue with world authorities. The number of seats available is strictly limited, first come-first serve*. The sessions will not be recorded.

There will be no formal presentation. The Session Leaders are present to answer your questions and to provide you with expert guidance.

Registration Fee: 20 euros

*These sessions are open to registered academic biologists and clinicians only.



Meet the Expert sessions programme







TIMING OF THE SCIENTIFIC PROGRAMME:

Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme
at a convenient hour, registration will allow participants to join both
the LIVE PROGRAMME: March 17-20, 2022 and the PROGRAMME ON-DEMAND: March 8 - April 20, 2022


The "live programme" will be streamed live CET time.
It will include Meet the Expert sessions,
interactive panel discussions, Q&A periods and Mentored Poster Walks.
It will also include some pre-recorded lectures that will be streamed live,
followed by their corresponding fully live Q&A period.


The “Programme on-demand” will soon be available.
It will initially include the pre-recorded components of the scientific programme.
It will be progressively enriched by the meeting’s live,
interactive components which will be recorded real time during the meeting.


E-POSTERS
March 8 - April 20, 2022
The Poster Hall will also remain open until April 20, 2022.
The Mentored Poster Walks scheduled in the LIVE PROGRAMME will also
become available in the PROGRAMME ON-DEMAND


VIRTUAL EXHIBITION
March 8 - April 20, 2022
We invite you to visit the Exhibition area as of March 8, 2022.
Our corporate partners will be pleased to welcome & chat with you.


SATELLITE SYMPOSIA LIVE AND ON-DEMAND:
Symposia organized independently by our corporate partners, in conjunction with
the ESH 2nd Translational Research E-Conference on CLL, will also be available Live and On-Demand..


The E-Conference has been reviewed and approved for CME-CPD accreditation by EBAH.
The EBAH has approved this educational activity for a maximum number of 7 CME-CPD credits




With the support of*:







Major E-Conference Partners
*******






Level 1 E-Conference Partners

*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.